Topic Intelligence
Articles and insights tagged intellectual-property on FAQSIR.
Lexaria Bioscience Corp. reports that its Human Pilot Study #7 is fully enrolled and that dosing is continuing on schedule across three study arms.
Lexaria Bioscience reported results from animal study GLP-1-A26-1, which evaluated DehydraTECH-CBD and DehydraTECH-semaglutide formulations and included a reported 566% improvement in mean brain absorption for one DHT-CBD formulation.
Tenon Medical announced 8 new patents issued by the USPTO so far in its 2026 fiscal year, covering systems and methods related to its Catamaran SI Joint Fusion System.
Applied Energetics has validated a next-generation ultrashort-pulse laser architecture and is constructing prototypes for an extended-range counter-drone system and a backpackable laser system.
SMX (Security Matters) PLC says its technology can embed molecular markers in luxury materials and link them to digital records covering provenance, authenticity and product history.
Oryzon Genomics said the USPTO issued a Notice of Allowance for a U.S. patent application covering iadademstat combinations with gilteritinib in myeloid cancers, including AML.
Oryzon Genomics reported financial results for the quarter and six months ended June 30, 2026, alongside updates on its AML, mental health and neurological disorder programmes.
Oryzon Genomics has reported a U.S. patent grant covering the use of vafidemstat and other LSD1 inhibitors for non-aggressive symptoms of borderline personality disorder.
Oryzon Genomics reported first-quarter 2026 financial results alongside updates on its oncology, haematology and CNS programmes, including ALICE-2, FRIDA and PORTICO-2.